{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:38:25Z","timestamp":1761763105731,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.urolonc.2020.09.021","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T08:04:38Z","timestamp":1601971478000},"page":"72.e1-72.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity"],"prefix":"10.1016","volume":"39","author":[{"given":"Ali","family":"Hajiran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan","family":"Zemp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet M.","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim K.","family":"Cheryian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio M.","family":"Pow-Sang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jad","family":"Chahoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.09.021_bib0001","first-page":"273","article-title":"Increased incidence of penile cancer and high-grade penile intraepithelial neoplasia in Denmark 1978-2008: a nationwide population-based study","volume":"23","author":"Baldur-Felskov","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0002","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1470-2045(04)01427-5","article-title":"Penile carcinoma: a challenge for the developing world","volume":"5","author":"Misra","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0003","doi-asserted-by":"crossref","first-page":"785","DOI":"10.21037\/tau.2017.05.19","article-title":"Updates on the epidemiology and risk factors for penile cancer","volume":"6","author":"Douglawi","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0004","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0094-0143(21)00387-6","article-title":"Penile cancer. Clinical presentation, diagnosis, and staging","volume":"19","author":"Burgers","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0005","first-page":"646","article-title":"The diagnosis and treatment of penile cancer","volume":"115","author":"Hakenberg","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0006","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/ijstd.IJSTD_106_17","article-title":"Premalignant male genital dermatoses","volume":"40","author":"Singhal","year":"2019","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/634216","article-title":"Organ-preserving surgery for penile carcinoma","author":"Martins","year":"2008","journal-title":"Adv Urol"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0008","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.juro.2007.07.039","article-title":"Mohs micrographic surgery for penile cancer: management and long-term followup","volume":"178","author":"Shindel","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0009","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1756287211412657","article-title":"Diagnosis and management of premalignant penile lesions","volume":"3","author":"Shabbir","year":"2011","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/ajd.12466","article-title":"Imiquimod in the treatment of penile intraepithelial neoplasia: an update","volume":"58","author":"Deen","year":"2017","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0011","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archderm.1970.04000020002002","article-title":"Fluorouracil: mechanism of action in human skin and actinic keratoses. I. effect on DNA synthesis in vivo","volume":"101","author":"Eaglstein","year":"1970","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0012","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2174\/138955706776876131","article-title":"Topical imiquimod: mechanism of action and clinical applications","volume":"6","author":"Vidal","year":"2006","journal-title":"Mini Rev Med Chem"},{"year":"2010","series-title":"AJCC cancer staging manual","author":"Edge","key":"10.1016\/j.urolonc.2020.09.021_bib0013"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0014","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00007611-196702000-00019","article-title":"Bowenoid conditions of the skin: treatment with topical 5-fluorouracil","volume":"60","author":"Jansen","year":"1967","journal-title":"South Med J"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0015","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.1975.03250090024012","article-title":"Erythroplasia of queyrat. treatment with topically applied fluorouracil","volume":"232","author":"Goette","year":"1975","journal-title":"Jama"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0016","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/1097-0142(197610)38:4<1498::AID-CNCR2820380409>3.0.CO;2-#","article-title":"Erythroplasia of queyrat: treatment with topical 5-fluorouracil","volume":"38","author":"Goette","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0017","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.eururo.2012.02.052","article-title":"Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents","volume":"62","author":"Alnajjar","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts. HPV study group. Human papilloma virus","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0019","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archdermatol.2008.562","article-title":"Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses","volume":"145","author":"Yentzer","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00128071-200607040-00004","article-title":"Pharmionics in dermatology: a review of topical medication adherence","volume":"7","author":"Lee","year":"2006","journal-title":"Am J Clin Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.urolonc.2020.09.021_bib0021","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1468-3083.2012.04525.x","article-title":"Adherence to topical treatment in psoriasis: a systematic literature review","volume":"26","author":"Devaux","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.urolonc.2020.09.021_bib0022","first-page":"35","article-title":"Non-adherence to topical treatments for actinic keratosis","volume":"8","author":"Shergill","year":"2013","journal-title":"Patient Prefer Adherence"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920304439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920304439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:20:36Z","timestamp":1761042036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920304439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1078143920304439"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.09.021","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}